Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

362 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

[Paraneoplastic chorea and behavioral disorders in a patient with anti-CV2/CRMP5 antibodies and two different tumors].

Ritzenthaler T, Verret JM, Honnorat J.

Rev Neurol (Paris). 2010 Jan;166(1):90-5. doi: 10.1016/j.neurol.2009.04.009. French.

0

0

0

PUBMED

Communication and Huntington's disease: qualitative interviews and focus groups with persons with Huntington's disease, family members, and carers.

Hartelius L, Jonsson M, Rickeberg A, Laakso K.

Int J Lang Commun Disord. 2010 May-Jun;45(3):381-93. doi: 10.3109/13682820903105145.

0

0

0

PUBMED

Injectable hydrogels providing sustained delivery of vascular endothelial growth factor are neuroprotective in a rat model of Huntington's disease.

Emerich DF, Mooney DJ, Storrie H, Babu RS, Kordower JH.

Neurotox Res. 2010 Jan;17(1):66-74. doi: 10.1007/s12640-009-9079-0.

0

0

0

PUBMED

Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease.

Ebert AD, Barber AE, Heins BM, Svendsen CN.

Exp Neurol. 2010 Jul;224(1):155-62. doi: 10.1016/j.expneurol.2010.03.005.

0

0

0

PUBMED

Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's disease.

Aziz NA, Pijl H, Frölich M, Schröder-van der Elst JP, van der Bent C, Roelfsema F, Roos RA.

Eur J Neurol. 2010 Feb;17(2):280-8. doi: 10.1111/j.1468-1331.2009.02798.x.

0

0

0

PUBMED

Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice.

Milnerwood AJ, Gladding CM, Pouladi MA, Kaufman AM, Hines RM, Boyd JD, Ko RW, Vasuta OC, Graham RK, Hayden MR, Murphy TH, Raymond LA.

Neuron. 2010 Jan 28;65(2):178-90. doi: 10.1016/j.neuron.2010.01.008.

0

0

0

PUBMED

Mitochondria in Huntington's disease.

Damiano M, Galvan L, Déglon N, Brouillet E.

Biochim Biophys Acta. 2010 Jan;1802(1):52-61. doi: 10.1016/j.bbadis.2009.07.012. Review.

0

0

0

PUBMED

Impaired ganglioside metabolism in Huntington's disease and neuroprotective role of GM1.

Maglione V, Marchi P, Di Pardo A, Lingrell S, Horkey M, Tidmarsh E, Sipione S.

J Neurosci. 2010 Mar 17;30(11):4072-80. doi: 10.1523/JNEUROSCI.6348-09.2010.

0

0

0

PUBMED

Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers.

Pavese N, Politis M, Tai YF, Barker RA, Tabrizi SJ, Mason SL, Brooks DJ, Piccini P.

Neurobiol Dis. 2010 Feb;37(2):356-61. doi: 10.1016/j.nbd.2009.10.015.

0

0

0

PUBMED

Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease.

Wood NI, Carta V, Milde S, Skillings EA, McAllister CJ, Ang YL, Duguid A, Wijesuriya N, Afzal SM, Fernandes JX, Leong TW, Morton AJ.

PLoS One. 2010 Feb 12;5(2):e9077. doi: 10.1371/journal.pone.0009077. Erratum in: PLoS One. 2010;5(9). doi: 10.1371/annotation/4a16d713-6dd6-4366-96a8-71d316456f98. Morton, Jennifer [corrected to Morton, A Jennifer].

0

0

0

PUBMED

Neuroinflammation in Huntington's disease.

Möller T.

J Neural Transm (Vienna). 2010 Aug;117(8):1001-8. doi: 10.1007/s00702-010-0430-7. Review.

0

0

0

PUBMED

Huntington's disease: pathogenesis to animal models.

Kumar P, Kalonia H, Kumar A.

Pharmacol Rep. 2010 Jan-Feb;62(1):1-14. Review.

0

0

0

PUBMED

Advances in the pharmacological management of Huntington's disease.

Frank S, Jankovic J.

Drugs. 2010 Mar 26;70(5):561-71. doi: 10.2165/11534430-000000000-00000. Review.

0

0

0

PUBMED

Neuroprotective effects of L-carnitine in a transgenic animal model of Huntington's disease.

Vamos E, Voros K, Vecsei L, Klivenyi P.

Biomed Pharmacother. 2010 Apr;64(4):282-6. doi: 10.1016/j.biopha.2009.06.020.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy